Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo

By                

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 499-506

Spandidos Publications

Access to resources Recommend Favorite

Pranlukast, a Cysteinyl Leukotriene Type 1 Receptor Antagonist, Attenuates the Progression but Not the Onset of Silica-Induced Pulmonary Fibrosis in Mice

By  

International Archives of Allergy and Immunology, Vol. 158, Iss. 3, 2012-02 ,pp. : 241-251

Karger

Access to resources Recommend Favorite

Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy

By Pagel-Langenickel Ines   Buttgereit Jens   Bader Michael   Langenickel Thomas  

Journal of Molecular Medicine, Vol. 85, Iss. 8, 2007-08 ,pp. : 797-810

Springer Publishing Company

Access to resources Recommend Favorite

The liver X receptor agonist AZ876 protects against pathological cardiac hypertrophy and fibrosis without lipogenic side effects

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 3, 2015-03 ,pp. : 273-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

The orphan receptor NOR1 participates in isoprenaline‐induced cardiac hypertrophy by regulating PARP‐1

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 11, 2015-06 ,pp. : 2852-2863

John Wiley & Sons Inc

Access to resources Recommend Favorite